Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain
Open Access
- 27 July 2024
- journal article
- research article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 23 (9) , 100819
Abstract
No abstract availableKeywords
Funding Information
- Ralph W and Grace M Showalter Research Trust Fund
- Indiana Clinical and Translational Sciences Institute
This publication has 75 references indexed in Scilit:
- The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidityJournal of Neural Transmission, 2024
- PSMD4 drives progression of hepatocellular carcinoma via Akt/COX2 pathway and p53 inhibitionHuman Cell, 2023
- Aging and age‐related diseases: from mechanisms to therapeutic strategiesBiogerontology, 2021
- Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s DiseaseMolecular Neurobiology, 2020
- An Augmented Multiple-Protease-Based Human Phosphopeptide AtlasCell Reports, 2015
- Ultradeep Human Phosphoproteome Reveals a Distinct Regulatory Nature of Tyr and Ser/Thr-Based SignalingCell Reports, 2014
- The Hallmarks of AgingCell, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The Revitalized Tau Hypothesis on Alzheimer's DiseaseArchives of Medical Research, 2010
- Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degenerationActa Neuropathologica, 2002